⟵ Back to Search Results

BGB-3111-112

Completed

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

Beigene Study ID info

BGB-3111-112

ClinicalTrials.gov ID info

NCT04470908

Study Overview

Sex: Male

Age: 18 Years / 65 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: Male

Age: 18 Years / 65 Years

Study Documents

Study Protocol Statistical Analysis Plan